On August 20th, in order to deepen school enterprise cooperation, promote the integration of industry, academia and research, and accelerate the transformation of scientific and technological achievements into practical productivity, Cui Yazhou, member of the Party Committee and Vice President of Shandong University of Traditional Chinese Medicine, Zhao Yangang, Secretary of the Party Committee of Shandong University of Traditional Chinese Medicine Marine Chinese Medicine Research Institute (Qingdao College of Traditional Chinese Medicine), and Gao Peng, Deputy Secretary of the Party Branch of Shandong University of Traditional Chinese Medicine Drug Research Institute (Traditional Chinese Medicine Health Industry Technology Research Institute), visited Singal Technology Group for inspection. They conducted in-depth exchanges on the key research and development areas, technological breakthroughs, and school enterprise cooperation of the subsidiary New Holy Era New Materials. Leaders such as Li Junfeng, Deputy Director of Licang District Science and Technology Bureau, and Zhao Jun, General Manager of New Holy Era New Materials, accompanied and received. The inspection team conducted in-depth research on the company's development history and strategic positioning in the group exhibition hall, and entered the pharmaceutical excipient research and development laboratory, external patch expert workstation, and external patch demonstration base to conduct on-site inspections of the research and development and large-scale production capabilities of New Holy Era New Materials in the pharmaceutical industry.

In the follow-up discussion, both parties discussed issues such as resource sharing, new research and development directions, and product incubation. The school stated that it will use this inspection activity as a starting point to anchor deep cooperation goals, fully leverage the advantages of both parties, and work together to create a new benchmark for school enterprise collaboration and mutual integration. As the only production-oriented enterprise in China that has registered its pharmaceutical excipients SIS and acrylic acid emulsion with the China Food and Drug Administration (CDE), New Holy Era New Materials has made multiple breakthroughs in the field of transdermal drug delivery in recent years. This school enterprise cooperation is an exploration of the collaborative innovation model of "university+enterprise+market", which is expected to further promote the deep integration of the industrial chain and talent chain, achieve more scientific and technological achievements from the laboratory to the production line and market, and inject new momentum into the high-quality development of the transdermal drug delivery industry.